Drug Trial Radar · NCT03771898
A Study of Intrathecal SHP611 in Children With Metachromatic Leukodystrophy
Last checked: Nov 20, 2026Latest source record: Jul 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
36
Actual
Start
May 13, 2019
Primary completion
Mar 8, 2023
Study completion May 6, 2026
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- Collaborators
- Takeda Development Center Americas, Inc.
- First posted
- Dec 11, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 6 months, up to 72 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main aim of the study is to determine if SHP611 given by injection into the spinal fluid that surrounds the brain and spinal cord (intrathecal; IT) prolongs the time for children with Metachromatic Leukodystrophy (MLD) to retain the ability to move from place to place. Other aims of the study are to determine the effects of intrathecal administration of SHP611 on movement and speech functions and to learn how well SHP611 injected in the spinal fluid that surrounds the brain and spinal cord is tolerated. Study participants will receive SHP611 for about 2 years with the possibility of an extended treatment period.
Conditions
- Metachromatic Leukodystrophy (MLD)
Interventions
SHP611Drug
Participants will receive 150 mg of SHP611 IT via IDDD or LP once weekly for 106 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Probability of Free of Loss of Locomotion in the Last Time Interval Up to 2 Years (Week 106) Based on GMFC-MLD for SHP611 Group A and GLIA-MLD Matched External ControlTime frame: Baseline up to Week 106
Locations
30 sites in 14 countries. Site status is shown where the registry gives one.
Los Angeles Biomedical Research Institute at Harbor-UCLA
Torrance, California
Childrens Hospital Colorado
Aurora, Colorado
Rare Disease Research, LLC
Atlanta, Georgia
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
University of Iowa Stead Family Children's Hospital
Iowa City, Iowa
Mayo Clinic - PPDS
Rochester, Minnesota
New York University Langone Medical Center
New York, New York
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania
University of Utah
Salt Lake City, Utah
Hospital Universitario Austral - PIN
Ciudad Autónoma Buenos Aires, Buenos Aires, Argentina
UZ Antwerpen
Edegem, Belgium
Hospital de Clínicas de Porto Alegre
Porto Alegre, Brazil
Stollery Children's Hospital University of Alberta
Edmonton, Alberta, Canada
British Columbia Children's Hospital
Vancouver, British Columbia, Canada
Hospital for Sick Children
Toronto, Ontario, Canada
Montreal Children's Hospital
Montreal, Quebec, Canada
Hôpital Bicêtre - Paris Sud
Le Kremlin-Bicêtre, France
CHU Lenval
Nice, France
Universitätsklinikum Hamburg Eppendorf
Hamburg, Germany
Universitätsklinikum Tübingen
Tübingen, Germany
Attikon University General Hospital
Chaïdári, Attica, Greece
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
IRCCS Ospedale Pediatrico Bambino Gesù - INCIPIT - PIN
Roma, Italy
Kanazawa University Hospital
Kanazawa, Japan
VU Medisch Centrum
Amsterdam, Netherlands
Hospital Vall d'Hebrón
Barcelona, Spain
Hospital Universitario Cruces
Barakaldo, Vizcaya, Spain
Birmingham Children's Hospital NHS Foundation Trust
Birmingham, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.